Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraperitoneal ondansetron for postoperative pain after elective caesarean section
IRCT20220610055121N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in postoperative pain, sponsored by Alborz University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Oct 2022; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220610055121N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220610055121N1.